These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 33816521)

  • 1. Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19.
    Issa H; Eid AH; Berry B; Takhviji V; Khosravi A; Mantash S; Nehme R; Hallal R; Karaki H; Dhayni K; Faour WH; Kobeissy F; Nehme A; Zibara K
    Front Med (Lausanne); 2021; 8():620990. PubMed ID: 33816521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptors: Impact for COVID-19 severity.
    Aksoy H; Karadag AS; Wollina U
    Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System.
    Sansoè G; Aragno M
    J Renin Angiotensin Aldosterone Syst; 2023; 2023():3362391. PubMed ID: 37476705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
    Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
    Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes.
    Calò LA; Rigato M; Sgarabotto L; Gianesello L; Bertoldi G; Ravarotto V; Davis PA
    Front Med (Lausanne); 2021; 8():647319. PubMed ID: 34017843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
    Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
    G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of Angiotensin-(1-7) in COVID-19 Treatment.
    Luna P; Fernanda Pérez M; Castellar-Lopez J; Chang A; Montoya Y; Bustamante J; Rosales-Rada W; Mendoza-Torres E
    Curr Protein Pept Sci; 2023; 24(1):89-97. PubMed ID: 36453502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
    Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
    mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases.
    El-Arif G; Khazaal S; Farhat A; Harb J; Annweiler C; Wu Y; Cao Z; Kovacic H; Abi Khattar Z; Fajloun Z; Sabatier JM
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
    Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H
    FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
    Sackin H
    Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells.
    Caputo I; Caroccia B; Frasson I; Poggio E; Zamberlan S; Morpurgo M; Seccia TM; Calì T; Brini M; Richter SN; Rossi GP
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
    Malek Mahdavi A
    Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients.
    Rahman MM; Hasan M; Ahmed A
    Rev Med Virol; 2021 Sep; 31(5):1-12. PubMed ID: 33426683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin system at the interface of COVID-19 infection.
    Gul R; Kim UH; Alfadda AA
    Eur J Pharmacol; 2021 Jan; 890():173656. PubMed ID: 33086029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.
    Osman IO; Melenotte C; Brouqui P; Million M; Lagier JC; Parola P; Stein A; La Scola B; Meddeb L; Mege JL; Raoult D; Devaux CA
    Front Immunol; 2021; 12():625732. PubMed ID: 34194422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
    Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY
    Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.